Cody Peer

24PUBLICATIONS
218CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Cancer geneticsMolecular targetsToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 27, 2026
Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 study.

|Oct 14, 2024
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82.

Susana S Najera, Christopher J Ricketts, Laura S Schmidt

|Aug 26, 2023
Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma.

Jerry T Wu, Adam Cheuk, Kristine Isanogle

|May 25, 2023
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.

Melissa L Abel, Nobuyuki Takahashi, Cody Peer

|May 10, 2023
Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD.

Michiyo Iba, Changyoun Kim, Somin Kwon

|May 01, 2023
Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group.

Katherine E Warren, Gilbert Vezina, Mark Krailo

Pageof 4

Frequent Collaborators

19 joint publications

William Douglas Figg

3 joint publications

Priya Shankarappa

3 joint publications

Mark R Gilbert

2 joint publications

Haiyan Lei